Etopophos 1136 mg, Pulver zur Herstellung einer Infusionslösung - Durchstechflasche(n) Swissmedic Key 53557031 Registration Holder Cheplapharm Schweiz GmbH Name Etopophos 1136 mg, Pulver zur Herstellung einer Infusionslösung Date of registration 28.08.1996 Introduction of Sequence 28.02.2000 ATC-Classification Etoposide (L01CB01) Revision date 04.04.2006 WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.16.10. Show package size Durchstechflasche(n) Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 364.57 Limitation Yes Limitation text
Deductible 10 % Consumer price 412.90 Feedback FB GTIN 7680535570310 Medication Code Synthetika Pharmacode 4756321 Disponibility
Composition Praeparatio cryodesiccata: etoposidi phosphas 1136.3 mg corresp. etoposidum 1000 mg, natrii citras anhydricus corresp. natrium 76.72 mg, dextranum 40, pro vitro. Packungsbestandteile Label Praeparatio cryodesiccata:
Galenic Form Lyophilisate Excipiens Active Agent Dose Etoposide Phosphate 1136.3 mg correspond Etoposide 1000 mg
BAG: Active Agent Dose Etoposide Phosphate 1136.3 mg
Inactive agents Dose Dextran 40 Natrii Citras Anhydricus
Source Data was imported : 07.02.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
